Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update.
The recommendations provided in this document represent a distillation of various experiences, as well as data obtained from published studies in the setting of substantial changes in antibiotic sensitivity. It is hoped that this revised compilation will provide a basis upon which future developments and advances can be made in the therapeutic approach to infectious complications of peritoneal dialysis.
Keane
W F
WF
Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, USA.
Alexander
S R
SR
Bailie
G R
GR
Boeschoten
E
E
Gokal
R
R
Golper
T A
TA
Holmes
C J
CJ
Huang
C C
CC
Kawaguchi
Y
Y
Piraino
B
B
Riella
M
M
Schaefer
F
F
Vas
S
S
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001431:Bacteriological Techniques; D004352:Drug Resistance, Microbial; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D006801:Humans; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000175:diagnosis / Q000209:etiology / Q000382:microbiology / Q000628:therapy*; D012008:Recurrence
D000900:Anti-Bacterial Agents